Background: Urinary bladder tumor is the seventh most common worldwide tumor . According to National Cancer Institute in Egypt , urinary bladder tumor constitutes 30% of all cancer cases with an incidence rate of 13.5/100,000 individuals. CD10 protein has been an immediate part in pathways of transduction that control cellular development , apoptosis , metastatic possibilities of cancer cells and influence on invasion .CD10 has prognostic incentive in bladder cancer. HER2/neu protein seems to assume a part in neoplastic cell and included in pathogenesis of urinary bladder carcinoma. Association of HER2 receptor in proliferation of invasive urothelial carcinomas has incited trials to HER2/neu targeted therapies in advanced diseases. Aim of work: To evaluate the immunohistochemical expression of CD10 and HER2/ neu with the pathological parameters of urothelial carcinoma of urinary bladder well as grade and stage versus chronic cystitis Methods: CD10 and HER2/neu expressions were retrospectively analysed by immunohistochemistry in 30 cases of chronic cystitis and 30 paraffinembedded specimens of patients with primary urothelial carcinoma (UC).The expressions were related to clinicopathological parameters ,well as grade and pathological stage Results: The immunohistochemial expression of CD10 and HER2/neu were negative(score 0) in chronic cystitis cases than urothelial carcinoma and was significantly (p < 0.05). Nineteen cases (63%) of primary urothelial carcinomas were positive for CD10 expression and 17 cases (56.7%) were positive for HER2/neu compared to chronic cystitis . The high grade of urothelial carcinoma and the high pathological stage were significantly connected with the high CD10 and HER2/neu expression (p < 0.05). Conclusion : High CD10 and HER2/neu expression was related to high grade and pathological stage of urothelial carcinoma. Keywords: CD10 -HER2/neu -urothelial carcinoma of urinary bladderImmunohistochemistry (IHC)
INTRODUCTION
rinary bladder tumor is the sixth most common tumor in the United States after lung tumor ,prostate tumor ,breast tumor ,lymphoma and colon tumor . It is the third most common tumor in men and the eleventh most common tumor in women [1] . According to National Cancer Institute in Egypt , urinary bladder tumor constitutes 30% of all cancer cases with an incidence rate of 13.5/100,000 individuals. [2] . In spite of the major cases of bladder cancers, presented with tumor located in the superficial layer of the urinary bladder wall, approximately 20-40% of the cases will present with invasive tumor [3] .
Urinary bladder cancer was morphologically heterogeneous; more than 90 % of urinary bladder cancers was urothelial carcinoma (TCC), where as primary squamous cell carcinoma (SCC) , small cell carcinoma , adenocarcinoma and other tumors are less common [4] . The detection of new biological markers, may prompt to the enhancement of therapeutic approaches and clinical prediction of bladder cancer cases with the purpose of decreasing the danger of progression. [5] . The CD10 (common acute lymphoblastic leukemia antigen) was a surface zincdependent enzyme metalloprotease that played role in inactivation of different bioactive neuropeptides [6] . The CD10 is /normally expressed in many tissues, including epithelial cells of the breast, kideny, intestine, prostate and lung; accordingly, disturbance of CD10 expression has been connected with development or progression in a variety of tumors [7] Conflicting results have been accounted in bladder urothelial carcinoma , with CD10 down regulation involved in progressive tumors, or, inversely, it is up regulation has been connected with invasion and metastasis [8] . The HER-2/neu ( human epidermal growth factor receptor 2) located by (c-erbB-2) gene that restricted to chromosome 17q21 and involved a transmembrane tyrosine kinase receptor protein As well as its value in controlling normal cellular proliferation, amplification of the HER2/neu gene ,appears to play a role in neoplastic cell growth [10] . Besides a role of HER2/neu in prognostic significance, assessment of Her-2/Neu expression in cases with urinary bladder cancer has been effected in therapeutic approaches [11] . This study aimed to assessed immunohistochemical expression of HER2/neu and CD10 in chronic cystitis and urothelial carcinoma of urinary bladder and their relation to pathological parameters as, histopathological grade and stage.
MATERIALS AND METHODS Patients and materials
The retrospective studied groups included random 30 cases of chronic cystitis (cystoscopic biopsies) and 30 cases of primary bladder UC selected from files archives of Pathology department , Faculty of Medicine, Zagazig University .Of theses 17 cases were selected by TRUB procedures and 13 cases by radical cystectomies .Only TRUB cases with muscle fibers were included in the study. Sections of hematoxylin and eosin were examined to confirm diagnosis. Grade of examined sections of urothelial carcinoma according to the classification of WHO 2016 [12] and were evaluated pathological stage (depth of invasion of urothelial carcinoma ) according to TNM staging system tumors [13] . The cytoplasm and or cell membrane staining was regarded as positive expression. A semiquantitative score depended on the percentage (%) of positive cells of the tumor was assessed with respect to this score, Score 0: Means that ( < 5%) of cells showed membrane and or cytoplasmic staining (negative ),Score 1: Means that (5-50%) of cells showed membrane and/or cytoplasmic staining (postive )and Score 2: Means that (>50%) of cells showed membrane and or cytoplasmic staining (postive ) [14] . Scoring of immunohistochemical expression of HER2/neu : sections of immunostaining were assessed under light microscope independently by two pathologists. Only membranous staining was regarded as positive with respect to this scoring : Score 0 :
Mean that no staining or membrane staining showed in < 10% of the tumor. Score 1:
Mean that Faint partial membrane staining showed in >10% of the tumor cells. (Fig. 2) 
B-
Immunohistochemical results of HER2/neu staining: All chronic cystitis cases were showed negative score of HER2/neu expression ( Fig  1) , while 17 cases of UC (56.7%) were a positive staining with statistically significant relation (p < 0.05) { Table 2} . A statistically significant relation between expression of HER2/neu and grading of UC (p < 0.05). High grade of UC were associated with higher HER2/neu expression. A significant statistical relation was observed between expression of HER2/neu and pathologic stage (p < 0.05) {Table 2} (Fig.  3) .
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-52- proliferation, apoptosis, differentiation , angiogenesis and metastasis . CD10 molecule participate in the control of cell growth, differentiation, adhesion, angiogenesis and invasion by enzymatic hydrolysis of different peptide hormones . These processes are important in normal physiology, in addition to development and progression of tumor [7] . In current study , expression of CD10 was detected in urothelial carcinoma in 63.3% (19 out of 30 cases) and completely absent in chronic cystitis .
In agreement with Kandemir et al [7] and Atique et al. [14] showed higher expression of CD10 was reported in urothelial carcinoma compared to non-neoplastic urothelium. In contrast with Murali et al. [15] detected expression of CD10 in 50% of non neoplastic urothelium samples and in 67% of urothelial carcinoma that his study take large samples of nonneoplastic lesions while Bircan et al. [16] were found CD10 expression in 9.9% of non neoplastic urothelium and in 43% of urothelial carcinoma.
As regard to our results, expression of CD10 in relation to grade of urothelial carcinoma , a positive rate of CD10 immunoreactivity was detected in 33.3% (4 out of 12 cases) of low grade tumor and 83.3%(15 out of 18 cases) in high grade of UC. CD10 expression showed statically significance relation with urothelial carcinoma grade (p=0.01), similar results were obtained by Murali et al. [15] ; Bahadir et al. [17] ; Kandemir et al. [7] ; Mohammed et al. [6] and Atique et al. [14] and disagreed with other studies were done by Koiso et al. [18] and Bircan et al. [16] Whom take large sample size for used As regard to our results , analyzed CD10 expression in relation to pathological stage (T) in urothelial carcinoma , CD10 expression was detected in 28.6% of PTa of tumors (2 out of 7 cases), 60% of PT1 of tumors (3 out of 5 cases), 75% of PT2 (6 out of 8 cases )and 80% of PT3 of tumors(8 out of 10 cases). There was satatically significance relation between CD10 expression and pathological stage of urothelial carcinoma (depth of invasion of tumors ) which was in agreement with a studies done by Abdou [19] and Bahadir et al.
[17] while disagreed with other study done by Kandemir et al. [7] . who found no significant correlation between immunohistochemical expression of CD10 The frequency of HER2/neu overexpression in urothelial carcinoma ranges between 12%
[21] and 71% [22] , these variations in reported rates of Her2/neu expression are due to differences in applied scoring criteria for the assessment of the HER2/neu overexpression or could to tumor heterogeneity , collecting samples and method used In the current study was used immunohistochemical method for assessment of HER2/neu expression, which was the most common method intended for breast tumor . This study showed positive expression of HER2/neu in 56.7% of urothelial carcinomas and this rate were within previously series of published data; Caner et al., [23] ; Naik et al., [20] and El Gehani et al., [22] confirming the effective of immunochistochemical method in the evaluation of HER2/neu expression in urothelial carcinoma .In agreement with AlTereihi et al. [24] and Hammam et al. [25] , all cases of chronic cystitis showed negative score of HER2/neu expression, whilst 56.7% cases of urothelial carcinoma showed positive scoring . The expression of HER2/neu was not identified in chronic cystitis cases so inflammatory urothelium seemed not to affect on HER2/neu expression. In comparison with Hammam et al. [26] that HER2/neu expressed in bilharzial cystitis because their study take a large sample of bilharzial cystitis, with significant difference (p < 0.05 
